FIELD: medicine.
SUBSTANCE: invention refers to medical products and concerns a pharmaceutical combination including vinpocetine and betahistine or its pharmaceutically acceptable salt for prevention and treatment of cerebral circulatory depression, containing 5-10 mg of vinpocetine and 8-16 mg of betahistine or its pharmaceutically acceptable salt. Also there are disclosed compositions including said combination.
EFFECT: combinations under the invention exhibits synergetic action.
7 cl, 5 dwg, 16 tbl, 6 ex
Authors
Dates
2010-04-20—Published
2008-06-23—Filed